404
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of HOMA-IR with Ovarian Sensitivity Index in Women Undergoing IVF/ICSI: A Retrospective Cohort Study

, , , &
Pages 309-320 | Received 25 Nov 2022, Accepted 24 Jan 2023, Published online: 02 Feb 2023

References

  • James DE, Stockli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance. Nat Rev Mol Cell Biol. 2021;22(11):751–771. doi:10.1038/s41580-021-00390-6
  • Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care. 2008;31(Suppl 2):S262–S268. doi:10.2337/dc08-s264
  • Mongraw-Chaffin M, Hairston KG, Hanley A, et al. Association of visceral adipose tissue and insulin resistance with incident metabolic syndrome independent of obesity status: the IRAS family study. Obesity. 2021;29(7):1195–1202. doi:10.1002/oby.23177
  • Xu Z-R, Du H-W, Cui L-W, et al. Association of β-cell function and insulin resistance with pediatric type 2 diabetes among Chinese children. World J Diabetes. 2021;12(8):1292–1303. doi:10.4239/wjd.v12.i8.1292
  • Banerjee D, Biggs ML, Mercer L, et al. Insulin resistance and risk of incident heart failure: cardiovascular health study. Circ Heart Fail. 2013;6(3):364–370. doi:10.1161/CIRCHEARTFAILURE.112.000022
  • Oka R, Yagi K, Sakurai M, et al. Impact of visceral adipose tissue and subcutaneous adipose tissue on insulin resistance in middle-aged Japanese. J Atheroscler Thromb. 2012;19(9):814–822. doi:10.5551/jat.12294
  • Sadeghi A, Fadaei R, Moradi N, et al. Circulating levels of c1q/tnf-alpha-related protein 6 (ctrp6) in polycystic ovary syndrome. Iubmb Life. 2020;72(7):1449–1459. doi:10.1002/iub.2272
  • Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38(9):1165–1174. doi:10.2337/diab.38.9.1165
  • Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980;50(1):113–116. doi:10.1210/jcem-50-1-113
  • Rosenthal M, Haskell WL, Solomon R, Widstrom A, Reaven GM. Demonstration of a relationship between level of physical training and insulin-stimulated glucose utilization in normal humans. Diabetes. 1983;32(5):408–411. doi:10.2337/diab.32.5.408
  • Jinno M, Kondou K, Teruya K. Low-dose metformin improves pregnancy rate in in vitro fertilization repeaters without polycystic ovary syndrome: prediction of effectiveness by multiple parameters related to insulin resistance. Hormones. 2010;9(2):161–170. doi:10.14310/horm.2002.1266
  • Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and reproductive disorders in women. Hum Reprod Update. 2003;9(4):359–372. doi:10.1093/humupd/dmg024
  • Yang T, Yang Y, Zhang Q, et al. Homeostatic model assessment for insulin resistance is associated with late miscarriage in non-dyslipidemic women undergoing fresh IVF/ICSI embryo transfer. Front Endocrinol. 2022;13:880518. doi:10.3389/fendo.2022.880518
  • Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030. doi:10.1210/er.2011-1034
  • Alebic MS, Bulum T, Stojanovic N, Duvnjak L. Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria. Endocrine. 2014;47(2):625–630. doi:10.1007/s12020-014-0182-5
  • Song H, Yu Z, Li P, Wang Y, Shi Y. Homa-ir for predicting clinical pregnancy rate during IVF. Gynecol Endocrinol. 2022;38(1):33–38. doi:10.1080/09513590.2021.1952976
  • Vural F, Vural B, Cakiroglu Y. The role of overweight and obesity in in vitro fertilization outcomes of poor ovarian responders. Biomed Res Int. 2015;2015:781543. doi:10.1155/2015/781543
  • Ubaldi F, Vaiarelli A, D’Anna R, Rienzi L. Management of poor responders in IVF: is there anything new? Biomed Res Int. 2014;2014:352098. doi:10.1155/2014/352098
  • Balen AH, Platteau P, Andersen AN, et al. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with world health organization group ii anovulatory infertility. BJOG. 2006;113(10):1195–1202. doi:10.1111/j.1471-0528.2006.01034.x
  • Mulders AG, Laven JS, Eijkemans MJ, Hughes EG, Fauser BC. Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Hum Reprod Update. 2003;9(5):429–449. doi:10.1093/humupd/dmg035
  • Homburg R. The management of infertility associated with polycystic ovary syndrome. Reprod Biol Endocrinol. 2003;1:109. doi:10.1186/1477-7827-1-109
  • Engmann L, Maconochie N, Bekir JS, Jacobs HS, Tan SL. Cumulative probability of clinical pregnancy and live birth after a multiple cycle IVF package: a more realistic assessment of overall and age-specific success rates? Br J Obstet Gynaecol. 1999;106(2):165–170. doi:10.1111/j.1471-0528.1999.tb08217.x
  • Grynberg M, Labrosse J. Understanding follicular output rate (fort) and its implications for Poseidon criteria. Front Endocrinol. 2019;10:246. doi:10.3389/fendo.2019.00246
  • Zheng Y, Pan Y, Li P, Wang Z, Wang Z, Shi Y. Ovarian sensitivity decreased significantly in patients with insulin resistance undergoing in vitro fertilization and embryo transfer. Front Physiol. 2021;12:809419. doi:10.3389/fphys.2021.809419
  • Huber M, Hadziosmanovic N, Berglund L, Holte J. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem. Fertil Steril. 2013;100(5):1270–1276. doi:10.1016/j.fertnstert.2013.06.049
  • Weghofer A, Barad DH, Darmon SK, Kushnir VA, Albertini DF, Gleicher N. The ovarian sensitivity index is predictive of live birth chances after IVF in infertile patients. Hum Reprod Open. 2020;2020(4):a49. doi:10.1093/hropen/hoaa049
  • Revelli A, Gennarelli G, Biasoni V, et al. The ovarian sensitivity index (osi) significantly correlates with ovarian reserve biomarkers, is more predictive of clinical pregnancy than the total number of oocytes, and is consistent in consecutive IVF cycles. J Clin Med. 2020;9:6. doi:10.3390/jcm9061914
  • Dickerson EH, Cho LW, Maguiness SD, Killick SL, Robinson J, Atkin SL. Insulin resistance and free androgen index correlate with the outcome of controlled ovarian hyperstimulation in non-pcos women undergoing IVF. Hum Reprod. 2010;25(2):504–509. doi:10.1093/humrep/dep393
  • Wang H, Zhang Y, Fang X, Kwak-Kim J, Wu L. Insulin resistance adversely affect IVF outcomes in lean women without pcos. Front Endocrinol. 2021;12:734638. doi:10.3389/fendo.2021.734638
  • La Marca A, Pati M, Giulini S, Levratti P, Caretto S, Volpe A. Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome? Gynecol Endocrinol. 2005;21(5):292–294. doi:10.1080/09513590500386983
  • Dale PO, Tanbo T, Haug E, Abyholm T. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome. Hum Reprod. 1998;13(3):567–570. doi:10.1093/humrep/13.3.567
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883
  • Eshre TR. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. doi:10.1016/j.fertnstert.2003.10.004
  • Consultation WE. Appropriate body-mass index for asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163. doi:10.1016/S0140-6736(03)15268-3
  • Biasoni V, Patriarca A, Dalmasso P, et al. Ovarian sensitivity index is strongly related to circulating amh and may be used to predict ovarian response to exogenous gonadotropins in IVF. Reprod Biol Endocrinol. 2011;9:112. doi:10.1186/1477-7827-9-112
  • Li HW, Lee VC, Ho PC, Ng EH. Ovarian sensitivity index is a better measure of ovarian responsiveness to gonadotrophin stimulation than the number of oocytes during in-vitro fertilization treatment. J Assist Reprod Genet. 2014;31(2):199–203. doi:10.1007/s10815-013-0144-5
  • Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115(4):e500–e503. doi:10.1542/peds.2004-1921
  • Coffler MS, Patel K, Dahan MH, Yoo RY, Malcom PJ, Chang RJ. Enhanced granulosa cell responsiveness to follicle-stimulating hormone during insulin infusion in women with polycystic ovary syndrome treated with pioglitazone. J Clin Endocrinol Metab. 2003;88(12):5624–5631. doi:10.1210/jc.2003-030745
  • Belani M, Purohit N, Pillai P, Gupta S, Gupta S. Modulation of steroidogenic pathway in rat granulosa cells with subclinical cd exposure and insulin resistance: an impact on female fertility. Biomed Res Int. 2014;2014:460251. doi:10.1155/2014/460251
  • Macut D, Simic T, Lissounov A, et al. Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress. Exp Clin Endocrinol Diabetes. 2011;119(7):451–455. doi:10.1055/s-0031-1279740
  • Safar FH, Mojiminiyi OA, Al-Rumaih HM, Diejomaoh MF. Computational methods are significant determinants of the associations and definitions of insulin resistance using the homeostasis model assessment in women of reproductive age. Clin Chem. 2011;57(2):279–285. doi:10.1373/clinchem.2010.152025
  • Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv. 2004;59(2):141–154. doi:10.1097/01.OGX.0000109523.25076.E2
  • Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril. 2002;77(6):1095–1105. doi:10.1016/s0015-0282(02)03111-4
  • Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril. 2001;75(2):310–315. doi:10.1016/s0015-0282(00)01675-7
  • Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med. 1998;338(26):1876–1880. doi:10.1056/NEJM199806253382603
  • De Leo V, la Marca A, Ditto A, Morgante G, Cianci A. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril. 1999;72(2):282–285. doi:10.1016/s0015-0282(99)00208-3
  • Nafiye Y, Sevtap K, Muammer D, Emre O, Senol K, Leyla M. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome. Fertil Steril. 2010;93(6):1864–1869. doi:10.1016/j.fertnstert.2008.12.024
  • Li Y, Yang D, Zhang Q. Impact of overweight and underweight on IVF treatment in Chinese women. Gynecol Endocrinol. 2010;26(6):416–422. doi:10.3109/09513591003632118
  • Spandorfer SD, Kump L, Goldschlag D, Brodkin T, Davis OK, Rosenwaks Z. Obesity and in vitro fertilization: negative influences on outcome. J Reprod Med. 2004;49(12):973–977.
  • van Swieten EC, van der Leeuw-Harmsen L, Badings EA, van der Linden PJ. Obesity and clomiphene challenge test as predictors of outcome of in vitro fertilization and intracytoplasmic sperm injection. Gynecol Obstet Invest. 2005;59(4):220–224. doi:10.1159/000084347
  • Wang JX, Davies MJ, Norman RJ. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res. 2002;10(6):551–554. doi:10.1038/oby.2002.74
  • Petanovski Z, Dimitrov G, Ajdin B, et al. Impact of body mass index (BMI) and age on the outcome of the IVF process. Prilozi. 2011;32(1):155–171.
  • Chen S, Chen Y, Liu X, et al. Insulin resistance and metabolic syndrome in normal-weight individuals. Endocrine. 2014;46(3):496–504. doi:10.1007/s12020-013-0079-8
  • Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15(1):83–96.
  • Buchanan TA, Watanabe RM, Xiang AH. Limitations in surrogate measures of insulin resistance. J Clin Endocrinol Metab. 2010;95(11):4874–4876. doi:10.1210/jc.2010-2167